Yifan Pharmaceutical Hits Day High with Strong 5.82% Intraday Surge

Yifan Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 5.82% on February 26, 2026. The stock reached an intraday high of CNY 13.62, showcasing its strong activity in the market. This performance stands in contrast to the China Shanghai Composite, which saw a decline of 1.26% on the same day. Over the past week, Yifan Pharmaceutical has shown a robust increase of 8.99%, further highlighting its positive momentum compared to the broader market. Year-to-date, the stock has risen by 9.53%, indicating a favorable trend amidst a challenging economic landscape. Despite some long-term growth concerns, as evidenced by a decline in net sales and operating profit over the past five years, Yifan Pharmaceutical has reported positive results for the last five consecutive quarters. The company boasts a high operating cash flow of CNY 786.16 million and a return on capital employed (ROCE) of 5.05%, reflecting improved operational efficiency. With a market capitalization of CNY 10,240 million, Yifan Pharmaceutical continues to navigate the pharmaceuticals and biotechnology sector with a notable presence.